Esperite NV (ESP) introduces Jouvene – Swiss Medicine Quintessence, the first combined offer of Stem Cells long term storage and highly accurate Whole Genome Sequencing for Consumer distribution.

June 4, 2019 Group News

Esperite NV (ESP) introduces Jouvene – Swiss Medicine Quintessence, the first combined offer of Stem Cells long term storage and highly accurate Whole Genome Sequencing for Consumer distribution.

Amsterdam, The Netherlands – 04 June 2019
read more

ESPERITE (ESP) announces termination of MoU regarding proposed sale of stem cell banking business to PBKM due to lack of agreement on the terms of the sale

May 29, 2019 Group News

ESPERITE (ESP) announces termination of MoU regarding proposed sale of stem cell banking business to PBKM due to lack of agreement on the terms of the sale

Amsterdam, The Netherlands – 29 May 2019
read more

Esperite (ESP) with The Cell Factory has confirmed a long-term effect of extracellular vesicle drug candidate CF-MEV-132 for the treatment of Bronchopulmonary Dysplasia.

February 27, 2019 Group News

CF-MEV-132 drug candidate belongs to the CF-MEV family of anti-inflammatory EV drugs produced by The Cell Factory

Amsterdam, The Netherlands – 27 February 2019
read more

ESPERITE NV (ESP) AND PBKM (FAMICORD GROUP) SIGN EXCLUSIVE AGREEMENT REGARDING POTENTIAL ACQUISITION OF CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS.

February 22, 2019 Group News

ESPERITE NV (ESP) AND PBKM (FAMICORD GROUP) SIGN EXCLUSIVE AGREEMENT REGARDING POTENTIAL ACQUISITION OF CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS.

Amsterdam, the Netherlands – 22 February 2019
read more

Page 1 of 1112345...10...Last »